{"name": "Cypress Bioscience",
 "permalink": "cypress-bioscience",
 "crunchbase_url": "http://www.crunchbase.com/company/cypress-bioscience",
 "homepage_url": "http://www.cypressbio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "ir-info@cypressbio.com",
 "phone_number": "858-452-2323",
 "description": "Bold Ideas, advancing medicine",
 "created_at": "Fri Jun 12 05:41:41 UTC 2009",
 "updated_at": "Fri Dec 17 04:01:52 UTC 2010",
 "overview": "\u003Cp\u003ECypress Bioscience, Inc. provides therapeutics and personalized medicine services to facilitate improved and individualized patient care. Cypress\u00e2\u20ac\u2122 goal is to address the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians, and expect that offering personalized medicine services and therapeutic products through the same sales organization will provide Cypress a differentiated commercial strategy and sustainable competitive advantage. Current products include SavellaTM (milnacipran HCI) and the Avise PGSM and Avise MCVSM therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       82],
      "assets/images/resized/0004/8126/48126v1-max-150x150.jpg"],
     [[217,
       119],
      "assets/images/resized/0004/8126/48126v1-max-250x250.jpg"],
     [[217,
       119],
      "assets/images/resized/0004/8126/48126v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chief Executive Officer and Chairman",
    "person":
     {"first_name": "Jay",
      "last_name": "D. Kranzler",
      "permalink": "jay-d-kranzler",
      "image":
       {"available_sizes":
         [[[99,
            150],
           "assets/images/resized/0004/8201/48201v1-max-150x150.jpg"],
          [[133,
            200],
           "assets/images/resized/0004/8201/48201v1-max-250x250.jpg"],
          [[133,
            200],
           "assets/images/resized/0004/8201/48201v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President, Chief Operating Officer and Chief Financial Officer",
    "person":
     {"first_name": "Sabrina",
      "last_name": "Martucci Johnson",
      "permalink": "sabrina-martucci-johnson",
      "image":
       {"available_sizes":
         [[[99,
            150],
           "assets/images/resized/0004/8202/48202v1-max-150x150.jpg"],
          [[133,
            200],
           "assets/images/resized/0004/8202/48202v1-max-250x250.jpg"],
          [[133,
            200],
           "assets/images/resized/0004/8202/48202v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President and Chief Commercial Officer",
    "person":
     {"first_name": "Michael",
      "last_name": "J. Walsh",
      "permalink": "michael-j-walsh",
      "image":
       {"available_sizes":
         [[[99,
            150],
           "assets/images/resized/0004/8205/48205v1-max-150x150.jpg"],
          [[133,
            200],
           "assets/images/resized/0004/8205/48205v1-max-250x250.jpg"],
          [[133,
            200],
           "assets/images/resized/0004/8205/48205v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 5000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://pittsburgh.bizjournals.com/pittsburgh/stories/2009/02/23/daily19.html",
    "source_description": "California company acquires Cellatope technology",
    "acquired_year": 2009,
    "acquired_month": 2,
    "acquired_day": 24,
    "company":
     {"name": "Cellatope",
      "permalink": "cellatope",
      "image": null}},
   {"price_amount": 75000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://deals.venturebeat.com/2008/02/26/%E2%80%9Cpersonalized-medicine%E2%80%9D-co-proprius-sells-to-cypress-bio-for-up-to-75m/",
    "source_description": "\"Personalized medicine\u00e2\u20ac\u009d co. Proprius sells to Cypress Bio for up to $75M",
    "acquired_year": 2008,
    "acquired_month": 2,
    "acquired_day": 26,
    "company":
     {"name": "Proprius",
      "permalink": "proprius",
      "image": null}}],
 "offices":
  [{"description": "Corporate Offices",
    "address1": "4350 Executive Drive",
    "address2": "Suite 325",
    "zip_code": "92121",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 32.875901,
    "longitude": -117.212163}],
 "milestones":
  [{"description": "Under fire, Cypress pledges $33M to acquire CNS programs\r\n",
    "stoned_year": 2010,
    "stoned_month": 8,
    "stoned_day": 26,
    "source_url": "http://www.fiercebiotech.com/story/under-fire-cypress-pledges-33m-acquire-cns-programs/2010-08-26?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Under fire, Cypress pledges $33M to acquire CNS programs",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cypress Bioscience",
      "permalink": "cypress-bioscience"}},
   {"description": "Cypress wrangles $255M buyout deal with Ramius",
    "stoned_year": 2010,
    "stoned_month": 12,
    "stoned_day": 15,
    "source_url": "http://www.fiercebiotech.com/story/cypress-wrangles-255m-buyout-deal-ramius/2010-12-15?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Cypress wrangles $255M buyout deal with Ramius",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cypress Bioscience",
      "permalink": "cypress-bioscience"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        67],
       "assets/images/resized/0004/8128/48128v1-max-150x150.jpg"],
      [[250,
        112],
       "assets/images/resized/0004/8128/48128v1-max-250x250.jpg"],
      [[450,
        203],
       "assets/images/resized/0004/8128/48128v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}